Infectious Disease Clinics of North America

Papers
(The median citation count of Infectious Disease Clinics of North America is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
COVID-19 Infection77
Powassan Virus Encephalitis56
Operationalization of Status Neutral Human Immunodeficiency Virus Care for Criminal-Legal Involved Populations56
Infectious Pulmonary Diseases52
Climate Change and Medical Mycology46
Occupational Health Update43
Vancomycin-Resistant Enterococci42
Contents40
COVID-19: Where We Are, Where We Need to Be40
Adult Long Coronavirus Disease 201938
Management of Unique Pneumonias Seen in the Intensive Care Unit38
Respiratory Tract Infections in the Postpandemic Era: A Return to Basics and Call to Action36
Tuberculosis in Children32
Medical Mycology in the Modern Era32
Contributors31
Health Care–Acquired Viral Respiratory Diseases29
Contributors29
Contents27
Device-Related Infections: Evolving Strategies for a Universal Problem27
Training the Next Generation of the Human Immunodeficiency Virus Workforce24
Cardiovascular Implantable Electronic Device Infections24
Forthcoming Issues22
Copyright22
Weight Gain and Antiretroviral Therapy22
Management of Children with Reported Penicillin Allergies20
Contributors19
Antibiotic Stewardship18
Advancing Toward a Human Immunodeficiency Virus Cure18
Updates in the Epidemiology, Approaches to Vaccine Coverage and Current Outbreaks of Measles18
Contents18
Outbreaks in Health Care Settings17
Epidemiology of Lyme Disease17
Mycobacteria in Organ Transplant Recipients15
Cerebrospinal Fluid Shunt Infections14
Switching Human Immunodeficiency Virus Therapy13
Diagnostic Stewardship in the Pediatric Intensive Care Unit12
Novel and Rapid Diagnostics for Common Infections in the Critically Ill Patient12
Contributors12
Contents12
Periprosthetic Joint Infection12
Contributors12
Vaccines for the Prevention of Coronavirus Disease 2019 in Older Adults12
Urinary Tract Infection Diagnostic and Management Considerations in People with Spinal Cord Injury and Neurogenic Bladder12
Behind Every Great Infection Prevention Program is a Great Microbiology Laboratory11
Pharmacologic Treatment and Management of Coronavirus Disease 201911
Infection Prevention and Control in Health Care, Part 1: Facility Planning and Management11
Reducing Treatment of Asymptomatic Bacteriuria11
The Role of the Infectious Disease Consultation in Lyme Disease11
Clinical Manifestations and Outcomes of SARS-CoV-2 Infection in Children and Adolescents11
Contributors10
The Intersection of Age and Infections: Understanding the Impacts from Diagnosis to Management10
Forthcoming Issues10
SARS-CoV-2 Transmission and Prevention in the Era of the Delta Variant10
Management and Prevention of Staphylococcus aureus Infections in Children9
HIV and Substance Use Disorders9
Contents9
COVID-19 Pathogenesis and Clinical Manifestations9
Implant-Associated Spinal Infections in Children9
Antibiotic Stewardship Interventions for Urinary Tract Infections in Outpatient Settings9
Untangling the Nuances Complicating Urinary Tract Infection Diagnosis and Management: Moving Beyond the Basics8
Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection8
Contributors8
Uses of Procalcitonin as a Biomarker in Critical Care Medicine8
Forthcoming Issues8
Diagnosing and Managing Urinary Tract Infections in Kidney Transplant Recipients8
Health Care Environmental Hygiene7
Contents7
Update in Human Immunodeficiency Virus and Aging7
Infections in the Critically Ill during the COVID-19 Pandemic: Infectious Diseases on Steroids7
Infections in Heart and Lung Transplant Recipients7
Antimicrobial Stewardship and the Infection Control Practitioner7
Sexually Transmitted Infections in Older Adults7
Forthcoming Issues7
COVID-19 in the Immunocompromised Host, Including People with Human Immunodeficiency Virus7
Viral Pneumonias7
Contents7
Forthcoming Issues6
Contact Lens-Related Corneal Infections6
Updates on Infection Control in Alternative Health Care Settings6
Opportunistic Infections Post-Lung Transplantation: Viral, Fungal, and Mycobacterial5
Contents5
Minimizing the Risk of Donor-Derived Events and Maximizing Organ Utilization Through Education and Policy Development5
Intravascular Catheter-Related Bloodstream Infections5
Blastomycosis5
An Update on Fungal Disease Outbreaks of Public Health Concern5
Severe Clostridioides difficile Infection in the Intensive Care Unit—Medical and Surgical Management5
Considering Patient, Family, and Provider Goals and Expectations in a Rapidly Changing Clinical Context: A Framework for Antimicrobial Stewardship at the End of Life5
Diagnostic Testing for Lyme Disease5
Invasive Aspergillosis in the Current Era5
Next-Generation Coronavirus Disease 2019 Vaccines5
Urinary Tract Infection in Male Patients5
Advances in Diagnostics of Sexually Transmitted Infections5
Copyright5
Copyright4
Advances in HIV Management During Pregnancy and Infant Feeding4
HIV Pre-Exposure Prophylaxis4
Contributors4
Advances in the Management of HIV4
After the COVID-19 Crisis: Update on Complex Infectious Diseases Issues in the Intensive Care Unit4
Contributors4
Challenges in Managing Gonorrhea and New Advances in Prevention4
Forthcoming Issues4
Human Granulocytic Anaplasmosis4
Copyright4
Contents4
Contributors4
Antimicrobial Resistance in Organ Transplant Recipients4
Copyright4
Fungal Nomenclature3
Antiviral Therapeutics in Pediatric Transplant Recipients3
Cytokine Release Syndrome and Sepsis3
The Impact of Coronavirus Disease 2019 (COVID-19) on Vulnerable Communities3
Computer Informatics for Infection Control3
Coronavirus Disease 2019 Management Strategies in Solid Organ Transplant Recipients3
Lyme Disease and the Expanded Spectrum of Blacklegged Tick-Borne Infections3
Infectious Disease Clinics of North America3
Novel Approaches to Multidrug-Resistant Infections in Cystic Fibrosis3
Epidemiology and Clinical Presentation of COVID-19 in Older Adults3
The Current State and Future Directions of Inpatient Pediatric Antimicrobial Stewardship3
Persistent Symptoms After Treatment of Lyme Disease3
Infection Prevention and Control in Health Care, Part II: Management of Infections3
Awakening3
Current Antifungals and the Developing Pipeline3
Contributors3
Navigating Coronavirus Disease 2019 in Immunocompromised Populations3
Urinary Tract Infection Challenges: Beyond the Basics2
Antimicrobial Stewardship at Transitions of Care2
Cryptococcosis2
Update in Epidemiology and Management of Mycoplasma genitalium Infections2
Methicillin-Resistant Staphylococcus aureus: An Update on Prevention and Control in Acute Care Settings2
Early Disseminated Lyme Disease2
ICU Management of Invasive β-Hemolytic Streptococcal Infections2
Approach to Managing Sex Partners of People with Sexually Transmitted Infections2
Lyme Arthritis2
Copyright2
Forthcoming Issues2
Forthcoming Issues2
Copyright2
Principles and Practice of Antimicrobial Stewardship Program Resource Allocation2
Emerging Diagnostics and Therapeutics for Invasive Fungal Infections2
Contents2
Updates in Molecular Diagnostics in Solid Organ Transplantation Recipients2
Forthcoming Issues1
Forthcoming Issues1
Forthcoming Issues1
Contributors1
The Current Pipeline of Antiretroviral Therapy1
Genital Herpes Infection1
Mucormycosis1
Copyright1
Contents1
Radiographic Imaging of Community-Acquired Pneumonia1
Contents1
Histoplasmosis1
Severe Acute Respiratory Syndrome Coronavirus 2 Immunology and Coronavirus Disease 2019 Clinical Outcomes1
Preparing the Intensive Care Unit for a Lethal Viral Respiratory Pandemic1
Infection Prevention and Control in Healthcare, Part I: Facility Planning1
Supportive Care in Patients with Critical Coronavirus Disease 20191
Updates in Cytomegalovirus Prevention and Treatment in Solid Organ Transplantation1
SARS-CoV-2 Virology1
COVID-19: How Far We’ve Come and Where We Need to Go Next1
The Urinary Microbiome1
Contemporary Treatment of Resistant Gram-Negative Infections in Pediatric Patients1
Antimicrobial Stewardship in Immunocompromised Patients1
0.047235012054443